↓ Skip to main content

Use of a Pharmaceutically Adulterated Dietary Supplement, Pai You Guo, Among Brazilian-Born Women in the United States

Overview of attention for article published in Journal of General Internal Medicine, August 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
2 news outlets
blogs
1 blog

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
116 Mendeley
Title
Use of a Pharmaceutically Adulterated Dietary Supplement, Pai You Guo, Among Brazilian-Born Women in the United States
Published in
Journal of General Internal Medicine, August 2011
DOI 10.1007/s11606-011-1828-0
Pubmed ID
Authors

Pieter A. Cohen, Carly Benner, Danny McCormick

Abstract

Pai You Guo is a weight loss supplement manufactured in China and adulterated with the banned pharmaceutical products sibutramine and phenolphthalein. The US Food and Drug Administration (FDA) announced a voluntary recall of Pai You Guo in 2009, yet clinicians have noted its continued use among Brazilian-born women in Massachusetts.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Lebanon 1 <1%
Luxembourg 1 <1%
Brazil 1 <1%
Unknown 113 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 20%
Student > Master 19 16%
Researcher 14 12%
Student > Ph. D. Student 12 10%
Student > Doctoral Student 6 5%
Other 20 17%
Unknown 22 19%
Readers by discipline Count As %
Medicine and Dentistry 31 27%
Social Sciences 14 12%
Nursing and Health Professions 12 10%
Psychology 8 7%
Agricultural and Biological Sciences 4 3%
Other 18 16%
Unknown 29 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 October 2018.
All research outputs
#1,349,521
of 23,911,072 outputs
Outputs from Journal of General Internal Medicine
#1,094
of 7,806 outputs
Outputs of similar age
#5,255
of 108,716 outputs
Outputs of similar age from Journal of General Internal Medicine
#3
of 49 outputs
Altmetric has tracked 23,911,072 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,806 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.8. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,716 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.